---
title: "Take Ltd (TAKE) — Share Price, Financials & Analysis"
symbol: "TAKE"
company: "Take Ltd"
canonical: "https://tapetide.com/stocks/TAKE"
isin: "INE142I01023"
nse_symbol: "TAKE"
bse_code: "532890"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 260.51
generated_at: "2026-09-13T18:21:44.132Z"
---

# Take Ltd (TAKE)

Canonical page: https://tapetide.com/stocks/TAKE

## Company

- **NSE Symbol:** TAKE
- **BSE Code:** 532890
- **ISIN:** INE142I01023
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2007-08-27
- **CEO:** Ms. Sonia Bhimrajka
- **Employees:** 2
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** takesolutions.com

## About

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

## Latest Price

- **Price:** ₹17.61
- **Change:** +0.83 (+4.95%)
- **Open:** ₹17.61
- **Day High:** ₹17.61
- **Day Low:** ₹16.78
- **Previous Close:** ₹16.78
- **Volume:** 317126
- **As Of:** 2026-09-11T09:32:44+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:41.511601Z.

- **Market Cap:** ₹260.51 Cr
- **Classification:** Microcap
- **P/E (reported):** 19.5
- **P/E (TTM):** 20.24
- **EPS (TTM):** ₹0.87
- **Book Value:** ₹2.1
- **Price to Book:** 8.07
- **Dividend Yield:** 0%
- **ROE:** 3.6%
- **ROCE:** 13.15%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹54.19 Cr
- **Net Income:** ₹10.85 Cr
- **EBITDA:** ₹-1.91 Cr
- **52-Week High:** ₹50.14
- **52-Week Low:** ₹10.09
- **RSI (14):** 41.99

## Tapetide Score

- **Score:** 34 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 4.9 (of 4473 scored stocks)
- **Confidence:** 89%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 90.38 | 9.89% |
| momentum | 3.49 | 13.19% |
| ownership | 48.29 | 26.37% |
| quality | 29.59 | 24.18% |
| valuation | 39.22 | 26.37% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 8.40 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -41.2% over past five years.
- Tax rate seems low
- Company has a low return on equity of -47.0% over last 3 years.
- Earnings include an other income of Rs.14.9 Cr.
- Working capital days have increased from -2,718 days to 123 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -275.64% | -181.77% | -112.1% |
| ebitda margin growth | -75% | -110.54% | -99.38% | -179.72% |
| net income growth | -75% | — | 27% | 15% |
| revenue growth | -46.63% | 431.27% | -34% | -41% |
| roce | -75.69% | -99.77% | -142.93% | — |
| roe | -75.69% | -99.52% | 236.15% | -108.95% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.19 | 30.37 |
| Expenses | 1.5 | 1.98 | 15.76 | 2.22 | 0.9 | 2.89 | 1.15 | 0.44 | 0.3 | 0.35 | 55.01 | 30.64 |
| Operating Profit | -1.45 | -1.98 | -15.76 | -2.22 | -0.9 | -2.89 | -1.15 | -0.44 | -0.3 | -0.35 | -0.82 | -0.27 |
| OPM % | -2900 | — | — | — | — | — | — | — | — | — | -1.51 | -0.89 |
| Other Income | 0.41 | 4.07 | -93.7 | -0.97 | -0.23 | 51.31 | -3.48 | -0.29 | 6.92 | 1.46 | 5.18 | 1.33 |
| Interest | 0.56 | 0.54 | 0.54 | 0.49 | 0.5 | 0.73 | 0.24 | 0.18 | 0.17 | 0 | 0 | 0 |
| Depreciation | 0.3 | 0.11 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -1.9 | 1.44 | -110.01 | -3.69 | -1.64 | 47.68 | -4.88 | -0.91 | 6.45 | 1.11 | 4.36 | 1.06 |
| Tax % | -18.42 | 248.61 | 0.55 | 1.63 | -3.66 | 0 | 0 | 0 | 2.48 | 0 | 0 | 0 |
| Net Profit | -1.55 | -2.14 | -110.61 | -3.75 | -1.58 | 47.68 | -4.88 | -0.91 | 6.29 | 1.11 | 4.36 | 1.06 |
| EPS in Rs | -0.1 | -0.14 | -7.48 | -0.25 | -0.11 | 3.22 | -0.33 | -0.06 | 0.43 | 0.08 | 0.29 | 0.07 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1587 | 2039 | 2213 | 774 | 655 | 189 | 4 | 0 | 54 | 85 |
| Expenses | 1281 | 1655 | 2044 | 847 | 648 | 208 | 24 | 7 | 56 | 86 |
| Operating Profit | 307 | 384 | 169 | -73 | 7 | -19 | -20 | -7 | -2 | -2 |
| OPM % | 19 | 19 | 8 | -9 | 1.1 | -10 | -569 | — | -3.5 | -2.1 |
| Other Income | 6 | 11 | 26 | -211 | -677 | -56 | -92 | 47 | 13 | 15 |
| Interest | 21 | 25 | 41 | 37 | 29 | 7 | 2 | 2 | 0 | 0 |
| Depreciation | 104 | 154 | 167 | 115 | 80 | 17 | 1 | 0 | 0 | 0 |
| Profit before tax | 188 | 216 | -13 | -437 | -779 | -99 | -116 | 37 | 11 | 13 |
| Tax % | 15 | 17 | -15 | 3 | 0 | 2 | 3 | 0 | 1 | — |
| Net Profit | 160 | 178 | -11 | -450 | -782 | -100 | -120 | 37 | 11 | 13 |
| EPS in Rs | 10.85 | 11.99 | -0.84 | -30.56 | -52.88 | -6.78 | -8.09 | 2.53 | 0.73 | 0.87 |
| Dividend Payout % | 15 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 13 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 898 | 1314 | 1504 | 1561 | 1110 | 166 | 94 | -24 | 6 | 16 |
| Borrowings | 237 | 323 | 474 | 553 | 514 | 59 | 46 | 37 | 0 | 0 |
| Other Liabilities | 221 | 189 | 339 | 336 | 187 | 984 | 69 | 60 | 16 | 5 |
| Total Liabilities | 1369 | 1840 | 2331 | 2465 | 1826 | 1223 | 224 | 88 | 36 | 36 |
| Fixed Assets | 554 | 589 | 1091 | 1234 | 934 | 101 | 73 | 30 | 0 | 0 |
| CWIP | 21 | 42 | 41 | 1 | 0 | 3 | 11 | 0 | 0 | 0 |
| Investments | 10 | 59 | 10 | 18 | 7 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 785 | 1150 | 1188 | 1213 | 885 | 1119 | 140 | 58 | 36 | 36 |
| Total Assets | 1369 | 1840 | 2331 | 2465 | 1826 | 1223 | 224 | 88 | 36 | 36 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 56 | 121 | 104 | 211 | 135 | 30 | 20 | 9 | -16 | -4 |
| Cash from Investing Activity | -130 | -179 | -474 | -233 | -57 | 15 | -3 | -7 | 22 | 2 |
| Cash from Financing Activity | 56 | 302 | 100 | 21 | -84 | -55 | -36 | -12 | -3 | -1 |
| Net Cash Flow | -18 | 243 | -270 | -2 | -6 | -10 | -18 | -10 | 3 | -3 |
| Free Cash Flow | -30 | 39 | -23 | 54 | 133 | -2 | -12 | 2 | -16 | -4 |
| CFO/OP | 26 | 44 | 30 | 156 | -212 | 704 | -114 | -43 | 217 | 208 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 118 | 108 | 94 | 116 | 205 | 45 | 58 | 715 | — | 1 |
| Inventory Days | — | — | — | — | — | — | — | — | — | 0 |
| Cash Conversion Cycle | 118 | 108 | 94 | 116 | 205 | 45 | 58 | 715 | — | 1 |
| Working Capital Days | 90 | 85 | 67 | 80 | 140 | 28 | -42 | -5559 | — | 123 |
| ROCE % | 17 | 15 | 13 | 1 | -9 | -6 | -14 | -22 | 11 | 19 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 53.41% | 53.41% | 53.41% | 53.41% | 53.41% | 53.41% | 53.41% | 53.34% | 5.19% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0.02% | 0% | 0% | 0% | 0% | 0% | 0% | 0.56% | 0.29% | 0.21% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0.01% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 39.4% | 39.39% | 39.39% | 39.35% | 39.78% | 40.15% | 40.45% | 40.49% | 40.4% | 38.8% | 31.59% | 29.63% |
| Others | 7.19% | 7.2% | 7.19% | 7.24% | 6.81% | 6.44% | 6.14% | 6.17% | 54.41% | 60.64% | 68.12% | 70.17% |
| No. of Shareholders | 81183 | 79336 | 81938 | 80288 | 78033 | 77163 | 75988 | 75141 | 74410 | 70324 | 64699 | 63213 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 5 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 15.09 | Buy |
| EMA (10) | 16.19 | Buy |
| SMA (20) | 17.64 | Sell |
| EMA (20) | 17.32 | Buy |
| SMA (50) | 20.24 | Sell |
| EMA (50) | 20.56 | Sell |
| SMA (100) | 25.98 | Sell |
| EMA (100) | 24.65 | Sell |
| SMA (200) | 33.14 | Sell |
| EMA (200) | 26.4 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.08 | Neutral |
| MACD (12,26,9) | -1.64 | Buy |
| Stochastic (14,3,3) | 54.44 | Neutral |
| ADX (14) | 38.43 | Buy |
| Williams %R (14) | -24.82 | Neutral |
| ATR (14) | 0.93 | High Volatility |
| ROC (12) | -1.45 | Sell |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 68.08 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 6 Apr - Take Solutions launches Rs 50 million innovation fund for AI, deep tech and digital health startups. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 Apr - Take Solutions launches Rs 50 million innovation fund for AI, deep tech and digital health startups.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1fb7484-2a96-43bf-9d53-3a2aaedf7f15.pdf) |
| 30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/472b57b3-23df-4228-912d-714f4ad56022.pdf) |
| 30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/472b57b3-23df-4228-912d-714f4ad56022.pdf) |
| 26 Mar - Board appointed A. Raghavendra Rao & Associates as statutory auditors effective March 26, 2026 to fill vacancy. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, 26Th March, 2026 26 Mar - Board appointed A. Raghavendra Rao & Associates as statutory auditors effective March 26, 2026 to fill vacancy.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80208406-e4eb-445d-b099-e64fe41e0106.pdf) |
| 26 Mar - Board appointed A. Raghavendra Rao & Associates as statutory auditors effective March 26, 2026 (subject to shareholders). | [Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 26 Mar - Board appointed A. Raghavendra Rao & Associates as statutory auditors effective March 26, 2026 (subject to shareholders).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ccbbc89f-5df7-47d0-bfa4-001e6dc09bb2.pdf) |
| 25 Mar - Venkat and Rangaa LLP resigned as Take Solutions' statutory auditor effective March 25, 2026, citing insufficient audit fees. | [Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors 25 Mar - Venkat and Rangaa LLP resigned as Take Solutions' statutory auditor effective March 25, 2026, citing insufficient audit fees.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90df0d7c-7319-479f-8df3-fc6d5ac3a936.pdf) |
| 25 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/year ending Mar 31, 2026. | [Closure of Trading Window 25 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/year ending Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12f023ed-9ac0-44ab-9548-ffa9c690f068.pdf) |
| 25 Mar - TAKE Solutions launches Take.Health AI health platform targeting India's $197B preventive healthcare market; subscription and enterprise focus. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 25 Mar - TAKE Solutions launches Take.Health AI health platform targeting India's $197B preventive healthcare market; subscription and enterprise focus.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b1d5bd5a-1bf7-4e78-ad34-0c55c2890d2b.pdf) |
| 21 Feb - 21 Feb 2026: Take Solutions integrates Anthropic's Claude to enhance AI-driven preventive healthcare platforms and Unified AI Marketplace. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 21 Feb - 21 Feb 2026: Take Solutions integrates Anthropic's Claude to enhance AI-driven preventive healthcare platforms and Unified AI Marketplace.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/74989fe0-d36b-4936-a944-afc35293c466.pdf) |
| 17 Apr - Take Solutions plans entry into India’s longevity and anti-ageing market with nutraceuticals and digital wellness products. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 17 Apr - Take Solutions plans entry into India’s longevity and anti-ageing market with nutraceuticals and digital wellness products.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/552516d9-adea-42f5-accb-3a24d9ebeb80.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a799ffc-6785-4a01-bfcf-b878b489293f.pdf) |
| 2026-09-07 | [Notice Of The 25Th Annual General Meeting For FY 2025-26 On Tuesday September 29 2026 At 12:00 P.M.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2c57772-982b-421b-871e-e617d14b4691.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28dd6062-f3f0-4ff2-975d-5ffb40d21e8a.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd32c343-bb4d-4e62-af90-1ad343668c1e.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday September 3 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=670bdaca-3065-4b11-9720-e73a88b15398.pdf) |
| 2026-09-01 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday September 1 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8061c474-db58-4443-b22d-bf53d4db4c8e.pdf) |
| 2026-08-17 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2367619-d214-40a5-9d88-1f1f54f61e2f.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9a8bd65-5df3-4734-b7bb-87d5f6f9cc0a.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1716ea1a-1c6a-484e-ae7b-ad68267e30b7.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cafd2ff4-9ba3-4347-8a0d-ae47bd299655.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82c84c4d-cc7a-425e-8c61-f7be6f8cb7c7.pdf) |
| 2026-05-20 | [Audited Financial Results For The Quarter And Financial Year Ended 31 March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f9f8667-1335-49b8-abec-96a903cc2265.pdf) |
| 2026-02-14 | [Results For The Quarter And Nine Months Ended 31 December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b87ec3f7-bc8d-4406-a9af-10ee8239b578.pdf) |
| 2025-10-27 | [Outcome Of Board Meeting Held On Monday October 27 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7f72ce7-422b-43a1-953d-e0ef3724acc5.pdf) |
| 2025-07-07 | [Outcome Of Board Meeting Held On Monday July 7 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=845ebc90-f412-4b99-8e9f-6be9b1bd01f3.pdf) |
| 2025-05-30 | [Outcome Of Board Meeting Held On May 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ec951c7-4e56-429c-aabf-81351dc237c7.pdf) |
| 2025-02-12 | [Outcome Of Board Meeting Held On Wednesday February 12 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d1eaa54-516f-43da-b402-b0ae6fd4345a.pdf) |
| 2025-01-22 | [Outcome Of The Board Meeting Held On Wednesday January 22 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35925539-f100-43ff-947f-3bddec41fe53.pdf) |
| 2025-01-22 | [Outcome Of The Board Meeting Held On Wednesday January 22 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=812402c0-73b3-42d8-ac26-6b8cb77d3870.pdf) |
| 2024-05-30 | [Outcome Of The Board Meeting Held On Thursday, May 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35933592-6168-40d4-b98a-0c902a5ff876.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8afc3af2-2f75-4aa6-8236-71d0b4786867.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a260696d-2b3f-41d0-bfc7-e20cf29d509f.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d52d1f0-bf7f-4f96-8ffa-319d1378138c.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3f335350-a218-4b39-b35d-ec377ad61970.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532890/69050532890.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532890/65366532890.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532890/5328900319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532890/5328900318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/532890/5328900317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/532890/5328900316.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fe8ea9a-83cc-4822-9b0b-4d8677f25174.pdf) |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/4fe8ea9a-83cc-4822-9b0b-4d8677f25174.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a0e7f6c-eb17-48c4-a9d7-dd10429e8416.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a0e7f6c-eb17-48c4-a9d7-dd10429e8416.pdf) |
| Feb 2019 | [Concall - Feb 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81336856-0f97-436c-98ca-b6e1d9244039.pdf) |
| Feb 2019 | [Concall - Feb 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/81336856-0f97-436c-98ca-b6e1d9244039.pdf) |
| Feb 2016 | [Concall - Feb 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46036BD1_E39F_4395_B45F_02D41EE5280B_161226.pdf) |
| Aug 2019 | [Concall - Aug 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c61931f3-b596-4c41-bf16-5394885c10ef.pdf) |
| Aug 2019 | [Concall - Aug 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c61931f3-b596-4c41-bf16-5394885c10ef.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:21:44.132Z.